| Identification | Back Directory | [Name]
Carbonic acid, [[(12aR)-12-[(8S)-5-fluoro-2-phenyl-8H-dibenzo[3,4:6,7]cyclohepta[1,2-b]thien-8-yl]-3,4,6,8,12,12a-hexahydro-6,8-dioxo-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazin-7-yl]oxy]methyl methyl ester | [CAS]
2485715-97-5 | [Synonyms]
Cap-dependent endonuclease-IN-7
Carbonic acid, [[(12aR)-12-[(8S)-5-fluoro-2-phenyl-8H-dibenzo[3,4:6,7]cyclohepta[1,2-b]thien-8-yl]-3,4,6,8,12,12a-hexahydro-6,8-dioxo-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazin-7-yl]oxy]methyl methyl ester | [Molecular Formula]
C36H28FN3O7S | [MOL File]
2485715-97-5.mol | [Molecular Weight]
665.69 |
| Hazard Information | Back Directory | [Uses]
Cap-dependent endonuclease-IN-7 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-7 Inhibits the synthesis of viral mRNA and eventually inhibits virus proliferation. Cap-dependent endonuclease-IN-7 has the potential for the research of viral infections (including influenza A, influenza B and influenza C) (extracted from patent WO2020177715A1, compound 5)[1] | [References]
[1] Qingyun Ren, et al. Influenza virus replication inhibitor and use thereof. Patent WO2020177715A1. |
|
|